Fig 1: ELISA confirms gene expression data in Fig. 4. Ldlr−/− mice were fed the four diets, and the levels of protein in jejunum mucus (except for osteopontin, which was determined in whole jejunum) were determined by ELISA as described in Materials and methods. The gender, age, and number of mice per group for each protein are shown in supplemental Table S3. A: Regenerating islet-derived family member 3 alpha (REG3A). B: Regenerating islet-derived family member 3 beta (REG3B). C: Lysozyme. D: Mucin 2 (MUC2). E: ApoA-I. F: Surfactant A. G: LPS-binding protein (LBP). H: Osteopontin. I: Immunoglobulin A (IgA). ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001.
Fig 2: Adding oxidized phospholipids ex vivo to jejunum from mice fed a chow diet reproduced the decrease in gene expression seen in jejunum from Ldlr−/− mice fed WD for genes whose protein products limit bacteria numbers or regulate the interaction of bacteria with enterocytes. Adding oxidized phospholipids together with chemically synthesized 6F peptide to jejunum ex vivo prevented the decrease, and in some cases increased gene expression above that seen in the absence of additions to the incubation. Jejunum segments from the mice described in Fig. 9 were incubated with no additions, or with oxidized phospholipids (Ox-PAPC) or with Ox-PAPC together with a control (Cont.) peptide or with Ox-PAPC together with chemically synthesized 6F peptide as described in Materials and methods. After 4 h of incubation gene expression was determined in the jejunum segments by RT-qPCR as described in Materials and methods for Reg3b (A), Reg3g (B), Alp1 (C), ApoA-I (D), Sftpa1(E), and Lyz (F). ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001.
Fig 3: A schematic representation of how the metabolism of a Western diet (WD) in the jejunum of Ldlr−/− mice could lead to systemic inflammation, and how apoA-I mimetics such as in a concentrate of transgenic tomatoes expressing the 6F peptide (Tg6F) could prevent this sequence of events. The metabolism of WD in the jejunum leads to increased levels of reactive oxygen species (ROS) and oxidized phospholipids in jejunum mucus. This leads to decreased levels of proteins required for the formation of functional goblet and Paneth cells in jejunum (ATOH1 and GFI1) and decreased levels of signaling molecules (Notch1 and Notch2) and interleukins (IL-36γ, IL-23, and IL-22) that are necessary for maintaining antimicrobial activity in jejunum. As a result, there are decreased numbers of goblet and Paneth cells and decreased antimicrobials in jejunum. Consequently, dysbiosis results including the virtual disappearance of a species (Akkermansia muciniphila) that is important for maintaining healthy mucus and regulating the levels of bacterial lipopolysaccharide (LPS) in mucus. This leads to increased levels of LPS in jejunum mucus, lymph, and plasma, which in turn leads to systemic inflammation (increased levels of serum amyloid A [SAA] and IL-6 in plasma). Tg6F protects against the increase in ROS and oxidized phospholipids, thus ameliorating this sequence of events.
Supplier Page from Abcam for Mouse Apolipoprotein AI Matched Antibody Pair Kit